As the global economy recovers in 2021 and the supply of the industrial chain improves, the Viral and Non-Viral Vector Manufacturing market will undergo major changes. According to the latest research, the market size of the Viral and Non-Viral Vector Manufacturing industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Viral and Non-Viral Vector Manufacturing industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Viral and Non-Viral Vector Manufacturing market during the next few years. The global Viral and Non-Viral Vector Manufacturing market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Viral and Non-Viral Vector Manufacturing market can be split based on product types, major applications, and important regions as follows:

North America
Europe
China
Japan
Southeast Asia
India
Korea

Player list
Boehringer Ingelheim
Catalent, Inc.
FUJIFILM Holdings Corporation
Danaher Corporation
Genscript Biotech Corporation
Lonza Group AG
Merck KGaA Inc.
Oxford Biomedica Plc
Sartorius AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Wuxi AppTec
Acuitas Therapeutics
Evonik Industries AG
Exelead, Inc.
Entos Pharmaceuticals
Genevant Sciences GmbH
T&T Scientific Corporation
Moderna, Inc.
CureVac N.V.

Types list
Viral Vectors
Non-Viral Vectors

Application list
Gene Therapy
Vaccinology
Cell Therapy
Others